India's Aurobindo Pharma has announced that its subsidiary Eugia Pharma Specialities has signed a voluntary sub-licensing agreement with Medicines Patent Pool to develop and market an anti-cancer drug- Nilotinib capsules. Nilotinib capsules are used for the treatment of chronic myeloid leukemia.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/bf8L5qu
via IFTTT
0 comments:
Post a Comment